Facing recurrent and intensifying climate shocks, FAO is scaling up a strategic intervention to secure Somali livelihoods. With a dedicated portfolio worth USD 70 million, half invested directly in ...

Credit: Boehringer Ingelheim. Nerandomilast reduces the expression of pro-fibrotic growth factors and inflammatory cytokines, commonly overexpressed in IPF. Findings showed nerandomilast led to a ...

Bubbles from Cary-Grove’s visiting bleachers, compliments of a student fan’s plastic wand and bottle, floated above Prairie Ridge’s football players. Nothing beats victory, however. Not even suds.

Anyone who has worked with AI has experienced the moment when it feels like the system is ignoring you. You ask for one thing, get something else, and then wonder why it worked perfectly yesterday but ...

If you’re buying a new TV, you’ll need to decide whether to use a TV stand or mount it on the wall. There are a number of good reasons why wall-mounting a TV can make sense. First, it can make the set ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Oral nerandomilast doses of 9 mg and 18 mg were ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Two differing nerandomilast doses were assessed against ...

Nerandomilast (BI 1015550) is an orally administered preferential inhibitor of phosphodiesterase 4B with antifibrotic and immunomodulatory properties. Nerandomilast has been shown to slow the ...

Race-neutral equations for assessing lung function appeared to catch more true-abnormal findings for Black patients than did previously standard race-adjusted spirometry equations, a study showed.

PureTech’s only internal drug program has slowed lung function decline in a phase 2 trial in idiopathic pulmonary fibrosis (IPF). The med, called deupirfenidone, is a deuterated form of Roche’s ...

Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated improvements in a respiratory health measure for patients with idiopathic ...